By: L. Herman MD, A. Servais MD, N. Blétard MD, Demolin MD, G. Houbiers MD, G. Namur MD, P. Reginster MD, C. Focan MD, PhD
This report presents a rare case of bilateral tonsillar metastases originating from colorectal adenocarcinoma. The implications of pharmacokinetic testing for tailored treatment in advanced-stage metastatic disease are also briefly reviewed. This case underlines the importance of accurate histopathological assessment, multidisciplinary collaboration, and pharmacogenetics in optimising patient outcomes.
(BELG J MED ONCOL 2025;19(2):68–72)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
